Abstract
The effect of taurine-containing drug on the development of visceral obesity in rats was studied
 with the syndrome of insulin resistance on the background of estrogen deficiency, which was kept on a high-fat diet. It was found that oral administration of taurine-containing drug, in the absence of
 stimulating effect on proliferative processes in the uterus, improves tolerance to
 carbohydrates and sensitivity to insulin, inhibits the development of abdominal obesity, weight gain
 body. The obtained results substantiate the prospects of using taurine-containing drug for pharmacological correction of the main components of postmenopausal metabolic
 syndrome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
